Tullis Health Investors

Tullis Health Investors is a well-established private equity firm dedicated exclusively to the healthcare sector, operating from Stamford, Connecticut. The firm distinguishes itself by focusing on middle-market companies across a broad spectrum of healthcare sub-sectors, including healthcare services, medical devices, diagnostics, and specialty pharmaceuticals. Their investment approach is flexible, encompassing growth equity, recapitalizations, buyouts, and structured equity investments, allowing them to tailor solutions to the specific needs of their portfolio companies.

The firm typically targets companies with revenues ranging from $10 million to $100 million and EBITDA between $2 million and $15 million, indicating a preference for businesses with established operations and proven profitability. Tullis Health Investors aims to deploy a significant amount of capital into each transaction, with a typical equity investment ranging from $10 million to $30 million. They also possess the capacity to facilitate larger investments through co-investments with partners, demonstrating their ability to support substantial growth initiatives.

Since its inception, Tullis Health Investors has built a robust track record, having raised over $500 million in capital across multiple funds. This substantial capital base has enabled them to complete more than 50 investments throughout their history, showcasing their deep experience and consistent activity within the healthcare investment landscape. Their long-standing presence and specialized focus underscore their commitment to fostering growth and value creation in the dynamic healthcare industry.